FDA Drug Application (050536) for ERYC by MAYNE PHARMA

Back to FDA Applications sponsored by MAYNE PHARMA

Application Number050536
Product Number001
FormCAPSULE, DELAYED REL PELLETS;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameERYC
Active IngredientERYTHROMYCIN

Active IngredientCount
List of drugs with Active Ingredient ERYTHROMYCIN29


Back to FDA Applications sponsored by MAYNE PHARMA